The 'Rules on the Standards for National Health Insurance Medical Care Benefits' revised and implemented by the MOHW on October 8 became the basis for negotiating all reimbursed drugs with the NHIS.

At the time, the pharmaceutical industry could not realize the 'power' of the rule amendment, but the NHIS emphasized that all drugs that need to be listed on the drug reimbursement list will go through a negotiation process through meetings with the pharmaceutical industry.

The specific basis is that Article 11-2, Paragraph 7 of the Rules, 'All drugs evaluated as having appropriate benefits shall be determined after negotiation within the range of 60 days'. All drugs for which the HIRA has e